核素治疗转移性骨癌骨痛的展望
Expectation of radionuclide analgesic therapy in patients with metastatic carcinoma of bone
-
摘要: 就目前临床上常用的几种治疗骨痛用核素药物的特点进行比较,并介绍一种被寄予厚望的、可由核素发生器生产的、188Re标记的药物188Re-HEDP,同时,就建立全国可行的核素治疗骨转移癌骨痛疗效的评定标准,提出了建议。Abstract: The characteristic of several common radioactive analgesics are compared. Also a greatly expected new drug, 188Re-HEDP is introduced for its superior radio-physical and radio-chemical property. At last, advice is given about the national-wide evaluating standard of radionuclide analgesic therapy of osteocopic pain.